What a buyer sees
BOOTS HEARINGCARE LIMITED
Other human health activities · Llandudno · 00823009
Your turnover is on public record
filedUnusual at this size, and it works in your favour: a buyer is reading your number rather than guessing at one.
What your filings show moving
How you sit in your trade
slowest tenth typical fastest tenth youEach spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.
What a buyer would ask 2
- A director resigned in the past yearA buyer will ask why, and will hear the answer from somewhere. Better from you.
- No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.
What a buyer would like 5
- 62 years of trading on fileLongevity is the cheapest evidence there is that the business is not one contract.
- Headcount grew from 716 to 800Growth a buyer can verify without asking you for anything.
- Sales per employee better than three quarters of your tradeYours is 212,048 against 41,178 for the middle of 53 comparable companies.
- Debtor days better than three quarters of your tradeYours is 12 against 27 for the middle of 50 comparable companies.
- Stock days better than three quarters of your tradeYours is 8 against 23 for the middle of 81 comparable companies.
What the register says
Owners
Nobody recorded with significant control.
Directors
- 58since 2017
- 50since 2023
- 50since 2024
- since 2025
- 56since 2026
- 56since 2026
| Year to | Filed | Turnover | Staff | Cash |
|---|---|---|---|---|
| 2026-03-31 | 2026-08-21 | £170M | 800 | £21M |
| 2024-03-31 | — | £146M | 716 | £11M |
| 2023-03-31 | — | £140M | 705 | £15M |
| 2022-03-31 | — | £142M | 623 | £16M |
| 2021-03-31 | — | £89M | 625 | £16M |
A rough bracket, and why it is only that
0.6–1.3× salesThe turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.